|
| Public Act 103-0196
|
| HB3613 Enrolled | LRB103 30213 RJT 56641 b |
|
|
AN ACT concerning education.
|
Be it enacted by the People of the State of Illinois,
|
represented in the General Assembly:
|
Section 5. The School Code is amended by changing Section |
22-30 as follows:
|
(105 ILCS 5/22-30)
|
Sec. 22-30. Self-administration and self-carry of asthma |
medication and epinephrine injectors; administration of |
undesignated epinephrine injectors; administration of an |
opioid antagonist; administration of undesignated asthma |
medication; asthma episode emergency response protocol.
|
(a) For the purpose of this Section only, the following |
terms shall have the meanings set forth below:
|
"Asthma action plan" means a written plan developed with a |
pupil's medical provider to help control the pupil's asthma. |
The goal of an asthma action plan is to reduce or prevent |
flare-ups and emergency department visits through day-to-day |
management and to serve as a student-specific document to be |
referenced in the event of an asthma episode. |
"Asthma episode emergency response protocol" means a |
procedure to provide assistance to a pupil experiencing |
symptoms of wheezing, coughing, shortness of breath, chest |
tightness, or breathing difficulty. |
|
"Epinephrine injector" includes an auto-injector approved |
by the United States Food and Drug Administration for the |
administration of epinephrine and a pre-filled syringe |
approved by the United States Food and Drug Administration and |
used for the administration of epinephrine that contains a |
pre-measured dose of epinephrine that is equivalent to the |
dosages used in an auto-injector. |
"Asthma medication" means quick-relief asthma medication, |
including albuterol or other short-acting bronchodilators, |
that is approved by the United States Food and Drug |
Administration for the treatment of respiratory distress. |
"Asthma medication" includes medication delivered through a |
device, including a metered dose inhaler with a reusable or |
disposable spacer or a nebulizer with a mouthpiece or mask.
|
"Opioid antagonist" means a drug that binds to opioid |
receptors and blocks or inhibits the effect of opioids acting |
on those receptors, including, but not limited to, naloxone |
hydrochloride or any other similarly acting drug approved by |
the U.S. Food and Drug Administration. |
"Respiratory distress" means the perceived or actual |
presence of wheezing, coughing, shortness of breath, chest |
tightness, breathing difficulty, or any other symptoms |
consistent with asthma. Respiratory distress may be |
categorized as "mild-to-moderate" or "severe". |
"School nurse" means a registered nurse working in a |
school with or without licensure endorsed in school nursing. |
|
"Self-administration" means a pupil's discretionary use of |
his or
her prescribed asthma medication or epinephrine |
injector.
|
"Self-carry" means a pupil's ability to carry his or her |
prescribed asthma medication or epinephrine injector. |
"Standing protocol" may be issued by (i) a physician |
licensed to practice medicine in all its branches, (ii) a |
licensed physician assistant with prescriptive authority, or |
(iii) a licensed advanced practice registered nurse with |
prescriptive authority. |
"Trained personnel" means any school employee or volunteer |
personnel authorized in Sections 10-22.34, 10-22.34a, and |
10-22.34b of this Code who has completed training under |
subsection (g) of this Section to recognize and respond to |
anaphylaxis, an opioid overdose, or respiratory distress. |
"Undesignated asthma medication" means asthma medication |
prescribed in the name of a school district, public school, |
charter school, or nonpublic school. |
"Undesignated epinephrine injector" means an epinephrine |
injector prescribed in the name of a school district, public |
school, charter school, or nonpublic school. |
(b) A school, whether public, charter, or nonpublic, must |
permit the
self-administration and self-carry of asthma
|
medication by a pupil with asthma or the self-administration |
and self-carry of an epinephrine injector by a pupil, provided |
that:
|
|
(1) the parents or
guardians of the pupil provide to |
the school (i) written
authorization from the parents or |
guardians for (A) the self-administration and self-carry |
of asthma medication or (B) the self-carry of asthma |
medication or (ii) for (A) the self-administration and |
self-carry of an epinephrine injector or (B) the |
self-carry of an epinephrine injector, written |
authorization from the pupil's physician, physician |
assistant, or advanced practice registered nurse; and
|
(2) the
parents or guardians of the pupil provide to |
the school (i) the prescription label, which must contain |
the name of the asthma medication, the prescribed dosage, |
and the time at which or circumstances under which the |
asthma medication is to be administered, or (ii) for the |
self-administration or self-carry of an epinephrine |
injector, a
written
statement from the pupil's physician, |
physician assistant, or advanced practice registered
nurse |
containing
the following information:
|
(A) the name and purpose of the epinephrine |
injector;
|
(B) the prescribed dosage; and
|
(C) the time or times at which or the special |
circumstances
under which the epinephrine injector is |
to be administered.
|
The information provided shall be kept on file in the office of |
the school
nurse or,
in the absence of a school nurse, the |
|
school's administrator.
|
(b-5) A school district, public school, charter school, or |
nonpublic school may authorize the provision of a |
student-specific or undesignated epinephrine injector to a |
student or any personnel authorized under a student's |
Individual Health Care Action Plan, Illinois Food Allergy |
Emergency Action Plan and Treatment Authorization Form, or |
plan pursuant to Section 504 of the federal Rehabilitation Act |
of 1973 to administer an epinephrine injector to the student, |
that meets the student's prescription on file. |
(b-10) The school district, public school, charter school, |
or nonpublic school may authorize a school nurse or trained |
personnel to do the following: (i) provide an undesignated |
epinephrine injector to a student for self-administration only |
or any personnel authorized under a student's Individual |
Health Care Action Plan, Illinois Food Allergy Emergency |
Action Plan and Treatment Authorization Form, plan pursuant to |
Section 504 of the federal Rehabilitation Act of 1973, or |
individualized education program plan to administer to the |
student that meets the student's prescription on file; (ii) |
administer an undesignated epinephrine injector that meets the |
prescription on file to any student who has an Individual |
Health Care Action Plan, Illinois Food Allergy Emergency |
Action Plan and Treatment Authorization Form, plan pursuant to |
Section 504 of the federal Rehabilitation Act of 1973, or |
individualized education program plan that authorizes the use |
|
of an epinephrine injector; (iii) administer an undesignated |
epinephrine injector to any person that the school nurse or |
trained personnel in good faith believes is having an |
anaphylactic reaction; (iv) administer an opioid antagonist to |
any person that the school nurse or trained personnel in good |
faith believes is having an opioid overdose; (v) provide |
undesignated asthma medication to a student for |
self-administration only or to any personnel authorized under |
a student's Individual Health Care Action Plan or asthma |
action plan, plan pursuant to Section 504 of the federal |
Rehabilitation Act of 1973, or individualized education |
program plan to administer to the student that meets the |
student's prescription on file; (vi) administer undesignated |
asthma medication that meets the prescription on file to any |
student who has an Individual Health Care Action Plan or |
asthma action plan, plan pursuant to Section 504 of the |
federal Rehabilitation Act of 1973, or individualized |
education program plan that authorizes the use of asthma |
medication; and (vii) administer undesignated asthma |
medication to any person that the school nurse or trained |
personnel believes in good faith is having respiratory |
distress. |
(c) The school district, public school, charter school, or |
nonpublic school must inform the parents or
guardians of the
|
pupil, in writing, that the school district, public school, |
charter school, or nonpublic school and its
employees and
|
|
agents, including a physician, physician assistant, or |
advanced practice registered nurse providing standing protocol |
and a prescription for school epinephrine injectors, an opioid |
antagonist, or undesignated asthma medication,
are to incur no |
liability or professional discipline, except for willful and |
wanton conduct, as a result
of any injury arising from the
|
administration of asthma medication, an epinephrine injector, |
or an opioid antagonist regardless of whether authorization |
was given by the pupil's parents or guardians or by the pupil's |
physician, physician assistant, or advanced practice |
registered nurse. The parents or guardians
of the pupil must |
sign a statement acknowledging that the school district, |
public school, charter school,
or nonpublic school and its |
employees and agents are to incur no liability, except for |
willful and wanton
conduct, as a result of any injury arising
|
from the
administration of asthma medication, an epinephrine |
injector, or an opioid antagonist regardless of whether |
authorization was given by the pupil's parents or guardians or |
by the pupil's physician, physician assistant, or advanced |
practice registered nurse and that the parents or
guardians |
must indemnify and hold harmless the school district, public |
school, charter school, or nonpublic
school and
its
employees |
and agents against any claims, except a claim based on willful |
and
wanton conduct, arising out of the
administration of |
asthma medication, an epinephrine injector, or an opioid |
antagonist regardless of whether authorization was given by |
|
the pupil's parents or guardians or by the pupil's physician, |
physician assistant, or advanced practice registered nurse. |
(c-5) When a school nurse or trained personnel administers |
an undesignated epinephrine injector to a person whom the |
school nurse or trained personnel in good faith believes is |
having an anaphylactic reaction, administers an opioid |
antagonist to a person whom the school nurse or trained |
personnel in good faith believes is having an opioid overdose, |
or administers undesignated asthma medication to a person whom |
the school nurse or trained personnel in good faith believes |
is having respiratory distress, notwithstanding the lack of |
notice to the parents or guardians of the pupil or the absence |
of the parents or guardians signed statement acknowledging no |
liability, except for willful and wanton conduct, the school |
district, public school, charter school, or nonpublic school |
and its employees and agents, and a physician, a physician |
assistant, or an advanced practice registered nurse providing |
standing protocol and a prescription for undesignated |
epinephrine injectors, an opioid antagonist, or undesignated |
asthma medication, are to incur no liability or professional |
discipline, except for willful and wanton conduct, as a result |
of any injury arising from the use of an undesignated |
epinephrine injector, the use of an opioid antagonist, or the |
use of undesignated asthma medication, regardless of whether |
authorization was given by the pupil's parents or guardians or |
by the pupil's physician, physician assistant, or advanced |
|
practice registered nurse.
|
(d) The permission for self-administration and self-carry |
of asthma medication or the self-administration and self-carry |
of an epinephrine injector is effective
for the school year |
for which it is granted and shall be renewed each
subsequent |
school year upon fulfillment of the requirements of this
|
Section.
|
(e) Provided that the requirements of this Section are |
fulfilled, a
pupil with asthma may self-administer and |
self-carry his or her asthma medication or a pupil may |
self-administer and self-carry an epinephrine injector (i) |
while in
school, (ii) while at a school-sponsored activity, |
(iii) while under the
supervision of
school personnel, or (iv) |
before or after normal school activities, such
as while in |
before-school or after-school care on school-operated
property |
or while being transported on a school bus.
|
(e-5) Provided that the requirements of this Section are |
fulfilled, a school nurse or trained personnel may administer |
an undesignated epinephrine injector to any person whom the |
school nurse or trained personnel in good faith believes to be |
having an anaphylactic reaction (i) while in school, (ii) |
while at a school-sponsored activity, (iii) while under the |
supervision of school personnel, or (iv) before or after |
normal school activities, such
as while in before-school or |
after-school care on school-operated property or while being |
transported on a school bus. A school nurse or trained |
|
personnel may carry undesignated epinephrine injectors on his |
or her person while in school or at a school-sponsored |
activity. |
(e-10) Provided that the requirements of this Section are |
fulfilled, a school nurse or trained personnel may administer |
an opioid antagonist to any person whom the school nurse or |
trained personnel in good faith believes to be having an |
opioid overdose (i) while in school, (ii) while at a |
school-sponsored activity, (iii) while under the supervision |
of school personnel, or (iv) before or after normal school |
activities, such as while in before-school or after-school |
care on school-operated property. A school nurse or trained |
personnel may carry an opioid antagonist on his or her person |
while in school or at a school-sponsored activity. |
(e-15) If the requirements of this Section are met, a |
school nurse or trained personnel may administer undesignated |
asthma medication to any person whom the school nurse or |
trained personnel in good faith believes to be experiencing |
respiratory distress (i) while in school, (ii) while at a |
school-sponsored activity, (iii) while under the supervision |
of school personnel, or (iv) before or after normal school |
activities, including before-school or after-school care on |
school-operated property. A school nurse or trained personnel |
may carry undesignated asthma medication on his or her person |
while in school or at a school-sponsored activity. |
(f) The school district, public school, charter school, or |
|
nonpublic school may maintain a supply of undesignated |
epinephrine injectors in any secure location that is |
accessible before, during, and after school where an allergic |
person is most at risk, including, but not limited to, |
classrooms and lunchrooms. A physician, a physician assistant |
who has prescriptive authority in accordance with Section 7.5 |
of the Physician Assistant Practice Act of 1987, or an |
advanced practice registered nurse who has prescriptive |
authority in accordance with Section 65-40 of the Nurse |
Practice Act may prescribe undesignated epinephrine injectors |
in the name of the school district, public school, charter |
school, or nonpublic school to be maintained for use when |
necessary. Any supply of epinephrine injectors shall be |
maintained in accordance with the manufacturer's instructions. |
The school district, public school, charter school, or |
nonpublic school may maintain a supply of an opioid antagonist |
in any secure location where an individual may have an opioid |
overdose. A health care professional who has been delegated |
prescriptive authority for opioid antagonists in accordance |
with Section 5-23 of the Substance Use Disorder Act may |
prescribe opioid antagonists in the name of the school |
district, public school, charter school, or nonpublic school, |
to be maintained for use when necessary. Any supply of opioid |
antagonists shall be maintained in accordance with the |
manufacturer's instructions. |
The school district, public school, charter school, or |
|
nonpublic school may maintain a supply of asthma medication in |
any secure location that is accessible before, during, or |
after school where a person is most at risk, including, but not |
limited to, a classroom or the nurse's office. A physician, a |
physician assistant who has prescriptive authority under |
Section 7.5 of the Physician Assistant Practice Act of 1987, |
or an advanced practice registered nurse who has prescriptive |
authority under Section 65-40 of the Nurse Practice Act may |
prescribe undesignated asthma medication in the name of the |
school district, public school, charter school, or nonpublic |
school to be maintained for use when necessary. Any supply of |
undesignated asthma medication must be maintained in |
accordance with the manufacturer's instructions. |
A school district that provides special educational |
facilities for children with disabilities under Section |
14-4.01 of this Code may maintain a supply of undesignated |
oxygen tanks in any secure location that is accessible before, |
during, and after school where a person with developmental |
disabilities is most at risk, including, but not limited to, |
classrooms and lunchrooms. A physician, a physician assistant |
who has prescriptive authority in accordance with Section 7.5 |
of the Physician Assistant Practice Act of 1987, or an |
advanced practice registered nurse who has prescriptive |
authority in accordance with Section 65-40 of the Nurse |
Practice Act may prescribe undesignated oxygen tanks in the |
name of the school district that provides special educational |
|
facilities for children with disabilities under Section |
14-4.01 of this Code to be maintained for use when necessary. |
Any supply of oxygen tanks shall be maintained in accordance |
with the manufacturer's instructions and with the local fire |
department's rules. |
(f-3) Whichever entity initiates the process of obtaining |
undesignated epinephrine injectors and providing training to |
personnel for carrying and administering undesignated |
epinephrine injectors shall pay for the costs of the |
undesignated epinephrine injectors. |
(f-5) Upon any administration of an epinephrine injector, |
a school district, public school, charter school, or nonpublic |
school must immediately activate the EMS system and notify the |
student's parent, guardian, or emergency contact, if known. |
Upon any administration of an opioid antagonist, a school |
district, public school, charter school, or nonpublic school |
must immediately activate the EMS system and notify the |
student's parent, guardian, or emergency contact, if known. |
(f-10) Within 24 hours of the administration of an |
undesignated epinephrine injector, a school district, public |
school, charter school, or nonpublic school must notify the |
physician, physician assistant, or advanced practice |
registered nurse who provided the standing protocol and a |
prescription for the undesignated epinephrine injector of its |
use. |
Within 24 hours after the administration of an opioid |
|
antagonist, a school district, public school, charter school, |
or nonpublic school must notify the health care professional |
who provided the prescription for the opioid antagonist of its |
use. |
Within 24 hours after the administration of undesignated |
asthma medication, a school district, public school, charter |
school, or nonpublic school must notify the student's parent |
or guardian or emergency contact, if known, and the physician, |
physician assistant, or advanced practice registered nurse who |
provided the standing protocol and a prescription for the |
undesignated asthma medication of its use. The district or |
school must follow up with the school nurse, if available, and |
may, with the consent of the child's parent or guardian, |
notify the child's health care provider of record, as |
determined under this Section, of its use. |
(g) Prior to the administration of an undesignated |
epinephrine injector, trained personnel must submit to the |
school's administration proof of completion of a training |
curriculum to recognize and respond to anaphylaxis that meets |
the requirements of subsection (h) of this Section. Training |
must be completed annually. The school district, public |
school, charter school, or nonpublic school must maintain |
records related to the training curriculum and trained |
personnel. |
Prior to the administration of an opioid antagonist, |
trained personnel must submit to the school's administration |
|
proof of completion of a training curriculum to recognize and |
respond to an opioid overdose, which curriculum must meet the |
requirements of subsection (h-5) of this Section. Training |
must be completed annually. Trained personnel must also submit |
to the school's administration proof of cardiopulmonary |
resuscitation and automated external defibrillator |
certification. The school district, public school, charter |
school, or nonpublic school must maintain records relating to |
the training curriculum and the trained personnel. |
Prior to the administration of undesignated asthma |
medication, trained personnel must submit to the school's |
administration proof of completion of a training curriculum to |
recognize and respond to respiratory distress, which must meet |
the requirements of subsection (h-10) of this Section. |
Training must be completed annually, and the school district, |
public school, charter school, or nonpublic school must |
maintain records relating to the training curriculum and the |
trained personnel. |
(h) A training curriculum to recognize and respond to |
anaphylaxis, including the administration of an undesignated |
epinephrine injector, may be conducted online or in person. |
Training shall include, but is not limited to: |
(1) how to recognize signs and symptoms of an allergic |
reaction, including anaphylaxis; |
(2) how to administer an epinephrine injector; and |
(3) a test demonstrating competency of the knowledge |
|
required to recognize anaphylaxis and administer an |
epinephrine injector. |
Training may also include, but is not limited to: |
(A) a review of high-risk areas within a school and |
its related facilities; |
(B) steps to take to prevent exposure to allergens; |
(C) emergency follow-up procedures, including the |
importance of calling 9-1-1 or, if 9-1-1 is not available, |
other local emergency medical services; |
(D) how to respond to a student with a known allergy, |
as well as a student with a previously unknown allergy; |
(E) other criteria as determined in rules adopted |
pursuant to this Section; and |
(F) any policy developed by the State Board of |
Education under Section 2-3.190. |
In consultation with statewide professional organizations |
representing physicians licensed to practice medicine in all |
of its branches, registered nurses, and school nurses, the |
State Board of Education shall make available resource |
materials consistent with criteria in this subsection (h) for |
educating trained personnel to recognize and respond to |
anaphylaxis. The State Board may take into consideration the |
curriculum on this subject developed by other states, as well |
as any other curricular materials suggested by medical experts |
and other groups that work on life-threatening allergy issues. |
The State Board is not required to create new resource |
|
materials. The State Board shall make these resource materials |
available on its Internet website. |
(h-5) A training curriculum to recognize and respond to an |
opioid overdose, including the administration of an opioid |
antagonist, may be conducted online or in person. The training |
must comply with any training requirements under Section 5-23 |
of the Substance Use Disorder Act and the corresponding rules. |
It must include, but is not limited to: |
(1) how to recognize symptoms of an opioid overdose; |
(2) information on drug overdose prevention and |
recognition; |
(3) how to perform rescue breathing and resuscitation; |
(4) how to respond to an emergency involving an opioid |
overdose; |
(5) opioid antagonist dosage and administration; |
(6) the importance of calling 9-1-1 or, if 9-1-1 is |
not available, other local emergency medical services; |
(7) care for the overdose victim after administration |
of the overdose antagonist; |
(8) a test demonstrating competency of the knowledge |
required to recognize an opioid overdose and administer a |
dose of an opioid antagonist; and |
(9) other criteria as determined in rules adopted |
pursuant to this Section. |
(h-10) A training curriculum to recognize and respond to |
respiratory distress, including the administration of |
|
undesignated asthma medication, may be conducted online or in |
person. The training must include, but is not limited to: |
(1) how to recognize symptoms of respiratory distress |
and how to distinguish respiratory distress from |
anaphylaxis; |
(2) how to respond to an emergency involving |
respiratory distress; |
(3) asthma medication dosage and administration; |
(4) the importance of calling 9-1-1 or, if 9-1-1 is |
not available, other local emergency medical services; |
(5) a test demonstrating competency of the knowledge |
required to recognize respiratory distress and administer |
asthma medication; and |
(6) other criteria as determined in rules adopted |
under this Section. |
(i) Within 3 days after the administration of an |
undesignated epinephrine injector by a school nurse, trained |
personnel, or a student at a school or school-sponsored |
activity, the school must report to the State Board of |
Education in a form and manner prescribed by the State Board |
the following information: |
(1) age and type of person receiving epinephrine |
(student, staff, visitor); |
(2) any previously known diagnosis of a severe |
allergy; |
(3) trigger that precipitated allergic episode; |
|
(4) location where symptoms developed; |
(5) number of doses administered; |
(6) type of person administering epinephrine (school |
nurse, trained personnel, student); and |
(7) any other information required by the State Board. |
If a school district, public school, charter school, or |
nonpublic school maintains or has an independent contractor |
providing transportation to students who maintains a supply of |
undesignated epinephrine injectors, then the school district, |
public school, charter school, or nonpublic school must report |
that information to the State Board of Education upon adoption |
or change of the policy of the school district, public school, |
charter school, nonpublic school, or independent contractor, |
in a manner as prescribed by the State Board. The report must |
include the number of undesignated epinephrine injectors in |
supply. |
(i-5) Within 3 days after the administration of an opioid |
antagonist by a school nurse or trained personnel, the school |
must report to the State Board of Education, in a form and |
manner prescribed by the State Board, the following |
information: |
(1) the age and type of person receiving the opioid |
antagonist (student, staff, or visitor); |
(2) the location where symptoms developed; |
(3) the type of person administering the opioid |
antagonist (school nurse or trained personnel); and |
|
(4) any other information required by the State Board. |
(i-10) Within 3 days after the administration of |
undesignated asthma medication by a school nurse, trained |
personnel, or a student at a school or school-sponsored |
activity, the school must report to the State Board of |
Education, on a form and in a manner prescribed by the State |
Board of Education, the following information: |
(1) the age and type of person receiving the asthma |
medication (student, staff, or visitor); |
(2) any previously known diagnosis of asthma for the |
person; |
(3) the trigger that precipitated respiratory |
distress, if identifiable; |
(4) the location of where the symptoms developed; |
(5) the number of doses administered; |
(6) the type of person administering the asthma |
medication (school nurse, trained personnel, or student); |
(7) the outcome of the asthma medication |
administration; and |
(8)
any other information required by the State Board. |
(j) By October 1, 2015 and every year thereafter, the |
State Board of Education shall submit a report to the General |
Assembly identifying the frequency and circumstances of |
undesignated epinephrine and undesignated asthma medication |
administration during the preceding academic year. Beginning |
with the 2017 report, the report shall also contain |
|
information on which school districts, public schools, charter |
schools, and nonpublic schools maintain or have independent |
contractors providing transportation to students who maintain |
a supply of undesignated epinephrine injectors. This report |
shall be published on the State Board's Internet website on |
the date the report is delivered to the General Assembly. |
(j-5) Annually, each school district, public school, |
charter school, or nonpublic school shall request an asthma |
action plan from the parents or guardians of a pupil with |
asthma. If provided, the asthma action plan must be kept on |
file in the office of the school nurse or, in the absence of a |
school nurse, the school administrator. Copies of the asthma |
action plan may be distributed to appropriate school staff who |
interact with the pupil on a regular basis, and, if |
applicable, may be attached to the pupil's federal Section 504 |
plan or individualized education program plan. |
(j-10) To assist schools with emergency response |
procedures for asthma, the State Board of Education, in |
consultation with statewide professional organizations with |
expertise in asthma management and a statewide organization |
representing school administrators, shall develop a model |
asthma episode emergency response protocol before September 1, |
2016. Each school district, charter school, and nonpublic |
school shall adopt an asthma episode emergency response |
protocol before January 1, 2017 that includes all of the |
components of the State Board's model protocol. |
|
(j-15) Every 2 years, school personnel who work with |
pupils shall complete an in-person or online training program |
on the management of asthma, the prevention of asthma |
symptoms, and emergency response in the school setting. In |
consultation with statewide professional organizations with |
expertise in asthma management, the State Board of Education |
shall make available resource materials for educating school |
personnel about asthma and emergency response in the school |
setting. |
(j-20) On or before October 1, 2016 and every year |
thereafter, the State Board of Education shall submit a report |
to the General Assembly and the Department of Public Health |
identifying the frequency and circumstances of opioid |
antagonist administration during the preceding academic year. |
This report shall be published on the State Board's Internet |
website on the date the report is delivered to the General |
Assembly. |
(k) The State Board of Education may adopt rules necessary |
to implement this Section. |
(l) Nothing in this Section shall limit the amount of |
epinephrine injectors that any type of school or student may |
carry or maintain a supply of. |
(Source: P.A. 101-81, eff. 7-12-19; 102-413, eff. 8-20-21; |
102-813, eff. 5-13-22.)
|
